We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns IriSys Over GMPs, Making Unapproved Drug
FDA Warns IriSys Over GMPs, Making Unapproved Drug
October 4, 2010
The FDA has warned IriSys for GMP violations and for manufacturing an unapproved new drug.